Laura Shawver
CIK 1551891 · Chief Executive Officer · last filed 2025-06-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.13M
Companies
6
Total Filings
35
Lifetime Open-Market Net
-$8.63M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SPRY | Director | 260,348 | $9.76 | $2.54M | -$8.63M | 15 | 2025-06-27 |
| RLAY | Director | 40,000 | $14.81 | $592.4K | $0 | 5 | 2024-06-05 |
| ARS Pharmaceuticals, Inc. (SBTX) Delisted | Chief Executive Officer | 254,242 | $5.87 | $1.49M | $0 | 4 | 2022-08-09 |
| NKTX | Director | — | $2.86 | — | $0 | 3 | 2022-06-10 |
| Synthorx, Inc. (THOR) Delisted | President and CEO | 215,595 | — | — | $0 | 5 | 2020-01-24 |
| CORNERSTONE THERAPEUTICS INC (CRTX) Delisted | Director | — | $1.95 | — | $0 | 3 | 2014-02-04 |
Recent Filings · Page 4 of 4
35 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-01-25 | Synthorx, Inc. (THOR) Delisted | Exer (M) | +25,000 | $15.8K | EDGAR |
| 2018-12-07 | Synthorx, Inc. (THOR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-02-04 | CORNERSTONE THERAPEUTICS INC (CRTX) Delisted | Disp (D) | — | $0 | EDGAR |
| 2013-05-23 | CORNERSTONE THERAPEUTICS INC (CRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-06-08 | CORNERSTONE THERAPEUTICS INC (CRTX) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 31–35 of 35
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.